CE mark
Geneseeq Nabs CE Marks for Residual Disease and Cancer Early Detection Tests
The MRD assay uses deep sequencing to detect cancer mutations in blood post-surgery and the early detection test involves multiomic analysis of cell-free DNA.
MedMira Gets CE Mark for COVID, Flu Combo Assay
The test is designed to detect SARS-CoV-2 and influenza A and B in a single nasal swab, according to the Canadian company.
Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
Premium
The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.
BioMérieux Gets CE Mark for Next-Gen Immunoassay System
The system runs the company's line of Vidas tests for emergency and critical care, immunochemistry, infectious diseases, and food industry pathogens.
SeekIn Receives CE-IVD Mark for Leukemia Cancer Mutation Detection Kit
The company's PanCanSeek test uses whole-genome sequencing to analyze bone marrow samples from leukemia patients, replacing a variety of more targeted technologies.
Nov 7, 2022
Cepheid Nabs CE Mark for Group B Strep Test
Oct 14, 2022
MedMira COVID-19 Antigen Test CE Marked
Oct 10, 2022
Ophiomics Liver Cancer Assay Gets CE-IVD Mark
Sep 12, 2022
SeekIn Nabs CE Mark for Cancer Assay
Sep 2, 2022
BGI Gets CE-IVD Mark for Thalassemia Test
Aug 31, 2022